These conversations are especially important for African American men, given the increased ambiguity due to the lack of PSA-based research specific to this population and increased risk of prostate cancer mortality attributed to late stage at diagnosis and more aggressive prostate cancer phenotypes seen in African American men. This evidence concerns the gene KLK3 and prostate cancer.